Unknown

Dataset Information

0

A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces ?-Amyloid-Associated Pathology, and Improves Cognition.


ABSTRACT: BACKGROUND:The ?4 isoform of apolipoprotein E (apoE4) is a major genetic risk factor for the development of sporadic Alzheimer's disease (AD), and its modification has been an intense focus for treatment of AD during recent years. METHODS:We investigated the binding of apoE, a peptide corresponding to its low-density lipoprotein receptor binding domain (amino acids 133-152; ApoEp), and modified ApoEp to amyloid precursor protein (APP) and their effects on amyloid-? (A?) production in cultured cells. Having discovered a peptide (6KApoEp) that blocks the interaction of apoE with N-terminal APP, we investigated the effects of this peptide and ApoEp on AD-like pathology and behavioral impairment in 3XTg-AD and 5XFAD transgenic mice. RESULTS:ApoE and ApoEp, but not truncated apoE lacking the low-density lipoprotein receptor binding domain, physically interacted with N-terminal APP and thereby mediated A? production. Interestingly, the addition of 6 lysine residues to the N-terminus of ApoEp (6KApoEp) directly inhibited apoE binding to N-terminal APP and markedly limited apoE- and ApoEp-mediated A? generation, presumably through decreasing APP cellular membrane trafficking and p44/42 mitogen-activated protein kinase phosphorylation. Moreover, while promoting apoE interaction with APP by ApoEp exacerbated A? and tau brain pathologies in 3XTg-AD mice, disrupting this interaction by 6KApoEp ameliorated cerebral A? and tau pathologies, neuronal apoptosis, synaptic loss, and hippocampal-dependent learning and memory impairment in 5XFAD mice without altering cholesterol, low-density lipoprotein receptor, and apoE expression levels. CONCLUSIONS:These data suggest that disrupting apoE interaction with N-terminal APP may be a novel disease-modifying therapeutic strategy for AD.

SUBMITTER: Sawmiller D 

PROVIDER: S-EPMC6642011 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition.

Sawmiller Darrell D   Habib Ahsan A   Hou Huayan H   Mori Takashi T   Fan Anran A   Tian Jun J   Zeng Jin J   Giunta Brian B   Sanberg Paul R PR   Mattson Mark P MP   Tan Jun J  

Biological psychiatry 20190502 3


<h4>Background</h4>The ɛ4 isoform of apolipoprotein E (apoE4) is a major genetic risk factor for the development of sporadic Alzheimer's disease (AD), and its modification has been an intense focus for treatment of AD during recent years.<h4>Methods</h4>We investigated the binding of apoE, a peptide corresponding to its low-density lipoprotein receptor binding domain (amino acids 133-152; ApoEp), and modified ApoEp to amyloid precursor protein (APP) and their effects on amyloid-β (Aβ) production  ...[more]

Similar Datasets

| S-EPMC3633722 | biostudies-literature
| S-EPMC4247163 | biostudies-literature
| S-EPMC5986716 | biostudies-literature
| S-EPMC6513189 | biostudies-literature
| S-EPMC4345559 | biostudies-literature
| S-EPMC5041108 | biostudies-literature
| S-EPMC5747997 | biostudies-literature
| S-EPMC7496786 | biostudies-literature
| S-EPMC2045076 | biostudies-literature
| S-EPMC6672812 | biostudies-literature